The investment case for hepatitis B and C in South Africa: adaptation and innovation in policy analysis for disease program scale-up. (2018)
Attributed to:
MRC Centre for Global Infectious Disease Analysis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/heapol/czy018
PubMed Identifier: 29529282
Publication URI: http://europepmc.org/abstract/MED/29529282
Type: Journal Article/Review
Volume: 33
Parent Publication: Health policy and planning
Issue: 4
ISSN: 0268-1080